Enhancing accountability in clinical governance leadership

In health, disability and aged care organisations, clinical governance is central to organisational purpose and community trust.

Boards rely on their clinical governance committee to provide informed oversight of care quality, safety, workforce capability and consumer outcomes. When the committee functions well, it strengthens assurance and supports early identification of emerging risks. When it does not, gaps can arise in escalation, reporting, culture or accountability.

A clinical governance committee effectiveness review provides a disciplined way to evaluate whether the committee is discharging its responsibilities effectively and providing the board with meaningful assurance.
This is a governance review, not a clinical audit.

Clinical governance committee effectiveness reviews are built on the CLEAR framework, which defines what effective oversight of quality, safety and consumer outcomes looks like at committee level.

The framework is structured around five domains:

• Committee purpose, role & composition - clear mandate, authority and expertise for effective oversight.
• Leadership, dynamics & operations - strong chair leadership, constructive challenge and disciplined meetings.
• Excellence in quality & safety - effective monitoring of safety risks, incidents and improvement.
• Assurance of workforce & practice - oversight of workforce capability, conduct and safe practice.
• Respecting consumer voice & rights - embedding consumer voice, rights and lived experience in governance.

Together, these domains provide a comprehensive and practical lens for assessing clinical governance committee effectiveness.

Clinical governance committee effectiveness reviews are typically conducted using a structured survey aligned to the CLEAR framework and may be supplemented by interviews to explore themes in greater depth.

The survey is completed by committee members and, where appropriate, by other directors and relevant executives who interact with the committee. Interviews may be conducted with the committee chair, selected members and key executives to add context and clarify findings.

The review focuses on governance effectiveness — including clarity of remit, leadership, quality of reporting, depth of oversight and committee culture — rather than operational clinical metrics.

Findings are synthesised into a clear report highlighting areas of strong governance practice and areas where oversight could be strengthened.

The report supports discussion between the committee chair and the board, focusing on how the committee fulfils its mandate, oversees safety and quality, escalates material issues and supports consumer-centred care.

The emphasis is on strengthening governance practice, not personalising results.

Boards value the clarity and reassurance an independent clinical governance committee review provides.

It strengthens confidence that safety and quality oversight is structured and disciplined, clarifies the committee’s mandate and role boundaries, and provides a defensible basis for demonstrating active governance of care standards and consumer outcomes.

Most importantly, it supports improved assurance to the board and reinforces the organisation’s commitment to safe, high-quality and respectful care.

Clinical governance committee effectiveness reviews are often conducted alongside board effectiveness reviews, risk committee effectiveness reviews and broader board skills or capability assessments.

Together, these reviews provide a coherent view of how well the board governs safety, quality, workforce and enterprise risk.

All clinical governance committee effectiveness reviews are conducted independently and confidentially.

Responses are aggregated and reported at committee and board level, supporting candid participation while preserving trust and constructive working relationships.